Skip to Content
Find More Like This
Return to Search

Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid

United States Patent

March 3, 2015
View the Complete Patent at the US Patent & Trademark Office
Brookhaven National Laboratory - Visit the Office of Technology Commercialization and Partnerships Website
(1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid also known as CPP-115 or its pharmaceutically acceptable salts can be used to treat addiction and neurological disorders such as epilepsy without side effects such as visual field defects caused by vigabatrin (Sabril).
Silverman; Richard B. (Northbrook, IL), Dewey; Stephen L. (Manorville, NY), Miller; Steven (Corona, CA)
Catalyst Pharmaceutical Partners (Coral Gables, FL), Brookhaven Science Associates (Upton, NY), Northwestern University (Evanston, IL)
13/ 581,187
February 25, 2011
GOVERNMENT SUPPORT This invention was made with government support under GM066132 awarded by the National Institutes of Health and DE-AC02-98CH10886 awarded by the Department of Energy. The government has certain rights in the invention.